<DOC>
	<DOCNO>NCT02367638</DOCNO>
	<brief_summary>The purpose study determine whether varicella live vaccine safe effective healthy adult .</brief_summary>
	<brief_title>Dose-escalation Phase 1 Evaluate Safety Efficacy MG1111 Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Chickenpox</mesh_term>
	<criteria>1 . Healthy male female individual 20 55 year age screen test In case female , individual must applicable one follow ; In case female childbearing potential , negative pregnancy test use urine hCG screen Menopausal least 2 year Surgical sterilization ( status hysterectomy , bilateral oophorectomy , bilateral tubal ligation status use contraceptive method ) Monogamous relationship vasectomize partner prior screen visit Individuals use acceptable contraceptive method 3 month prior subject 's study entry 1 month vaccination ( acceptable contraceptive method ; condom , diaphragm cervical cap ) 2 . If male sexually active female `` childbearing potential '' , individual agree use acceptable contraceptive method study period agree donate sperm 1 month 3 . At screen visit , individual 55 kg man , 50kg woman whose ideal body weight within 20 % ( ( ideal body weight = ( height 100 ) *0.9 ) 4 . Individual clinically significant abnormality screen test within 28 day prior vaccination 5 . Individuals voluntarily sign informed consent form receive education study able comply requirement study 1 . Individuals receive vaccine within 4 week prior screen visit 2 . Individuals plan receive vaccine study 3 . Individuals wind , scar , tattoo , dermatological disorder injection affect safety evaluation 4 . Individuals alcohol caffeine abuse heavy smoker ( caffeine : &gt; 5 cups/day , alcohol : 210g/week , smoke : 10 /day ) 5 . Individuals receive investigational product within 90 day prior vaccination 6. individual donate whole blood within 60 day apheresis within 30 day prior vaccinate investigational product 7 . Individuals administer another prescription medicine , herbal medicine within 14 day overthecounter drug vitamin within 7 day vaccination 8 . Individuals history illness affect immune system ( 1 ) individual continuously antiviral therapy within 6 month prior participate study ( 2 ) Individuals leukemia , lymphoma , malignant neoplasm hematodyscrasia affect bone marrow lymphatic system ( 3 ) Immunodeficient individual ( primary acquire immunodeficiency state , immunodeficiency , hypogammaglobulinemia , dysgammaglobulinemia ) ( 4 ) Individuals receive immunosuppressive therapy ( 5 ) Individuals treat immunoglobulin bloodderived product within 6 month enrollment ( 6 ) Individuals family history congenital hereditary immunodeficiency 9 . Individuals clinically relevant history disease disorder gastrointestinal , respiratory , renal , hepatic , neurological ( GuillainBarre syndrome ) , psychiatric malignant tumor 10 . Individuals febrile illness body temperature ≥38℃ vaccination 11 . Individuals know hypersensitivity allergy component investigational product ( include gelatin neomycin ) 12 . Individuals clinically significant abnormality follow investigator 's review prestudy physical examination , ECG , clinical laboratory test 13 . Pregnancy breastfeed 14 . Any ineligible condition discretion investigator would ineligible participate study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>